## Abstract ## Background In cancer, tumor escape from the host immune system includes apoptosis of circulating CD3^+^CD8^+^ effector T lymphocytes. Here, we compare sensitivity to apoptosis of virusβ with tumorβspecific circulating CD8^+^ T cells in patients with head and neck cancer. ## Methods
Mutagen-induced chromosome fragility within peripheral blood lymphocytes of head and neck cancer patients
β Scribed by Dr. Stimson P. Schantz; T. C. Hsu
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 615 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
β¦ Synopsis
The expression of chromosome breakage as a response to mutagen exposure may contribute to the development of head and neck cancer. Lymphocytes from 46 previously untreated head and neck cancer patients were cultured in vitro and exposed to the radiomimetic clastogen, bleomycin. The lymphocytes were then arrested in metaphase and analyzed for bleomycin-induced chromosome breaks. Mean bleomycin-induced chromosome breaks per cell (b/c) in head and neck cancer patients (0.94 2 0.3 b/c) were significantly higher than in either controls (0.70 * 0.3 b/c; p < 0.001) or a concurrently examined patient population with central nervous system tumors (0.55 -t 0.3 b/c; p < 0.001). The expression of mutagen-induced chromosome fragility in the head and neck cancer population was site-specific, being most evident in patients with laryngeal or pharyngeal cancer but not oral cavity disease. The differential responses to mutagen effects may be a reflection of DNA repair deficiency. Head and neck cancer patients express a higher degree of chromosomal mutagen sensitivity, which may contribute to neoplastic development. HEAD & NECK 11:337-342, 1989 Studies on chromosome instability in some individuals suggest that such a phenotype may have
π SIMILAR VOLUMES
Patients with head and neck squamous cell carcinoma (HNSCC) have profound immune deficiencies. In 65% of these patients, there is an increased intra-tumoral presence of immune-suppressive CD34 Ψ progenitor cells. The goal of the present study was to determine whether CD34 Ψ cell levels were also inc